[ Price : $8.95]
FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Breyanzi (lisocabtagene maraleucel; liso-cel) as a pot...[ Price : $8.95]
FDA accepts a Lantheus NDA for a new formulation of its Pylarify F 18 prostate-specific membrane antigen imaging agent.[ Price : $8.95]
FDA warns Glendora, CA-based Oasis Medical about CGMP violations in its production of finished drugs.[ Price : $8.95]
Right-wing commentator Laura Loomer publicly criticizes FDA commissioner Marty Makary over recent comments surrounding the departu...[ Price : $8.95]
Former FDA chief of staff Elizabeth Jungman joins law firm Hogan Lovells as a partner in its pharmaceuticals and biotechnology pra...[ Price : $8.95]
Vertex Pharmaceuticals says it will not pursue its investigational VX-993 as monotherapy for acute pain following bunionectomy sur...[ Price : $8.95]
FDA publishes the FY 2025 Quarter 2 update to the CBER/CDER Data Standards Program Action Plan.[ Price : $8.95]
FDA grants Clarametyx Biosciences both fast track and qualified infectious disease product designations for its lead therapeutic c...